GSK

  • Anoro 2021 report

    Anoro 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Benlysta 2021 report

    Benlysta 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Bexsero 2021 report

    Bexsero 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Blenrep 2021 report

    Blenrep 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Boostrix 2021 report

    Boostrix 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Fluarix 2021 report

    Fluarix 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Flulaval 2021 report

    Flulaval 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Jemperli 2021 report

    Jemperli 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Menveo 2021 report

    Menveo 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Nucala 2021 report

    Nucala 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Pediarix 2021 report

    Pediarix 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Shingrix 2021 report

    Shingrix 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 21 Pages The 5 Key Questions Addressed by this Report:...